Literature DB >> 170733

Ruptured benign hepatoma associated with an oral contraceptive. A case report.

A E Stenwig, T Solgaard.   

Abstract

A ruptured benign hepatoma is described in a woman at full-term pregnancy. The patient had used an oral contraceptive for eight years before she became pregnant. According to several recent reports it seems likely that there is a relationship between the use of oral contraceptive agents and the development of liver cell tumours. Twentythree such cases have been found in the literature. Fourteen of these were not diagnosed before rupture. The present tumour differed from previously described lesions by containing foci of haematopoietic cells. As there were no signs of blood or bone marrow disease, it is suggested that the extramedullary haematopoiesis is a constituent of the tumour tissue.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 170733     DOI: 10.1007/bf01239340

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histol        ISSN: 0340-1227


  25 in total

1.  Peliosis hepatis. Possible etiologic role of anabolic steroids.

Authors:  F Naeim; P H Copper; A A Semion
Journal:  Arch Pathol       Date:  1973-04

2.  Hepatoma and peliosis hepatis developing in a patient with Fanconi's anemia.

Authors:  M S Bernstein; R L Hunter; S Yachnin
Journal:  N Engl J Med       Date:  1971-05-20       Impact factor: 91.245

3.  Peliosis hepatis associated with androgenic-anabolic steroid therapy. A severe form of hepatic injury.

Authors:  S A Bagheri; J L Boyer
Journal:  Ann Intern Med       Date:  1974-11       Impact factor: 25.391

4.  Letter: Peliosis hepatis after long-term administration of oxymetholone.

Authors:  G Groos; O H Arnold; G Brittinger
Journal:  Lancet       Date:  1974-05-04       Impact factor: 79.321

5.  Letter: Benign hepatoma and oral contraceptives.

Authors:  C Tountas; G Paraskevas; H Deligeorgi
Journal:  Lancet       Date:  1974-06-29       Impact factor: 79.321

6.  Letter: Benign hepatomas and oral contraceptives.

Authors:  D R Kelso
Journal:  Lancet       Date:  1974-02-23       Impact factor: 79.321

7.  Letter: Hepatomas and oral contraceptives.

Authors:  J W Berg; R J Ketalaar; E F Rose; R G Vernon
Journal:  Lancet       Date:  1974-08-10       Impact factor: 79.321

8.  Association of androgenic-anabolic steroid therapy with development of hepatocellular carcinoma.

Authors:  F L Johnson; K G Lerner; M Siegel; J R Feagler; P W Majerus; J R Hartmann; E D Thomas
Journal:  Lancet       Date:  1972-12-16       Impact factor: 79.321

9.  Letter: Hepatoblastoma associated with an oral contraceptive.

Authors:  P Meyer; V LiVolsi; J L Cornog
Journal:  Lancet       Date:  1974-12-07       Impact factor: 79.321

10.  Liver hamartomas in patients on oral contraceptives.

Authors:  J P O'Sullivan; R P Wilding
Journal:  Br Med J       Date:  1974-07-06
View more
  3 in total

1.  Multiple hepatocellular tumours in a patient treated with oral contraceptives.

Authors:  W L Brander; G Vosnides; C S Ogg; I E West
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1976-04-05

Review 2.  Pregnancy and liver disease.

Authors:  M M Steven
Journal:  Gut       Date:  1981-07       Impact factor: 23.059

Review 3.  Malignant transformation of hepatocellular adenomas into hepatocellular carcinomas: a systematic review including more than 1600 adenoma cases.

Authors:  Jan H M B Stoot; Robert J S Coelen; Mechteld C De Jong; Cornelis H C Dejong
Journal:  HPB (Oxford)       Date:  2010-10       Impact factor: 3.647

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.